During the past decade, CCBR - Lodz - PL conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR - Lodz - PL" #1 collaborator was "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "OCT Clinical Trials" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CCBR - Lodz - PL" are "Rheumatoid Arthritis" (3 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "CCBR - Lodz - PL" in a lesser frequency.

Most popular intervention types in "CCBR - Lodz - PL" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "GDC-0853" (2 trials), "Adalimumab" (1 trials), "Concomitant treatment" (1 trials), "Folic Acid" (1 trials) and "MTX" (1 trials). Other intervention names were less common.

The vast majority of trials in "CCBR - Lodz - PL" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CCBR - Lodz - PL". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CCBR - Lodz - PL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CCBR - Lodz - PL, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".